# Post-P14 Follow-up Plan Review — AgentMiMo（2026-05-22）

## Verdict

**PASS_WITH_FINDINGS**

Artifact `docs/reviews/post-p14-follow-up-planning-20260522.md` passes all five review lenses with one LOW finding. The recommended next gate `P15-S1 production tracking_error golden evidence plan-review` is the correct smallest-next-step that directly serves design goals, has no scope creep, and is code-generation-ready for the next plan artifact.

## Review Input

| Item | Value |
|---|---|
| Reviewed artifact | `docs/reviews/post-p14-follow-up-planning-20260522.md` |
| Design truth | `docs/design.md` |
| Control truth | `docs/implementation-control.md` |
| Branch | `docs/post-p14-follow-up-planning` |
| Base | `main` at `fb68b17` |
| Excluded input | `docs/repo-audit-20260521.md`（observed as untracked, not read） |

## Lens 1: Is P15-S1 the best next step?

**PASS.**

Design truth direct evidence:

- `design.md` §3.4: index fund `preferred_lens` prioritizes 跟踪误差（tracking error） as first-look metric.
- `design.md` §4.4: 否决项 — 跟踪误差过大 > 2% for index funds.
- `design.md` §7.2: Golden Answer pipeline is the mechanism that locks correctness.

Control truth direct evidence:

- P13 created typed `index_profile` / `tracking_error` fields and direct annual-report extraction.
- P14 made these fields conditional P1 quality denominators for `index_fund` / `enhanced_index`.
- P14 closeout explicitly records: "no production `tracking_error` golden rows were added."
- Active Residuals table lists "Future tracking-error / index methodology / constituents extraction" as next.

The artifact's first-principles argument is sound: the remaining root-cause gap closest to the P13/P14 path is not missing calculation or audit architecture — it is that no production reviewed golden row currently proves the direct `tracking_error` value from a real selected fund. This is the smallest step that directly serves the design's evidence-auditable correctness goal.

No other candidate is more tightly coupled to P14's accepted residuals while also having lower scope risk.

## Lens 2: Is the candidate comparison sufficient?

**PASS.**

All 8 candidates are compared:

| Candidate | Covered? | Verdict alignment |
|---|---|---|
| production tracking_error golden evidence | Yes — selected | Correct |
| methodology / constituents extraction | Yes — deferred | Correct; requires new extraction semantics |
| calculated tracking error / external adapter | Yes — deferred | Correct; requires new source boundary |
| QDII tracking-error subtype | Yes — deferred | Correct; requires subtype design policy |
| E1-E3 / Evidence Confirm | Yes — deferred | Correct; design truth keeps this as future architecture |
| evidence-display / ITEM_RULE cleanup | Yes — deferred | Correct; less directly tied to P14 residuals |
| repo-hygiene D-1/D-8-C5/C-9 | Yes — excluded | Correct; see Finding F1 for minor inconsistency |
| RR-13 duplicate 016492 | Yes — excluded | Correct; human-owned identity conflict |

Comparison columns (product value, scope/boundary risk, decision) are sufficient for selection. Each deferral has a stated reason tied to scope risk, not arbitrary sequencing.

## Lens 3: Is there scope creep?

**PASS.**

No scope creep detected. The artifact's Non-goals section (lines 87-96) explicitly excludes:

- Implementation in this artifact
- Calculated tracking error, external index series, methodology/constituents extraction
- QDII subtype redesign
- E1/E2/E3, Evidence Confirm, LLM writing, semantic audit, RepairContract, Dayu runtime
- Changes to `ExtractionMode`, snapshot schema, quality gate severity, Service/UI/API contract, renderer behavior
- Benchmark-only evidence as proof of `tracking_error` value
- RR-13 data modification or source CSV changes
- Reading `docs/repo-audit-20260521.md`
- Updating `docs/design.md` or `docs/implementation-control.md`

These boundaries align with design truth (§1.2 确定性 MVP 主链路, §1.3 非目标) and control truth (Resume checklist, Active Residuals).

## Lens 4: Are stop conditions, evidence requirements, success signals, and residual owners clear?

**PASS.**

- **Stop condition** (line 68): "stop before implementation if no production reviewed direct `tracking_error` evidence can be proven from current repository artifacts."
- **Evidence requirements** (lines 63-67): exact fund code, year, annual-report section/table/row evidence anchor, `field_name`, `sub_field`, `expected_value`, confidence, source text.
- **Success signals** (lines 116-135): two-outcome framing — either accepted evidence-backed golden rows are added and validated, or blocker is recorded and next phase is routed to source-contract/evidence acquisition.
- **Validation commands** (lines 123-130): targeted golden prefill tests, extraction snapshot/score tests, sample matrix regression, strict golden JSON schema validation, ruff check, full pytest with no regression from P14 `428 passed`, `git diff --check HEAD`.
- **Residual owners** (lines 99-112): 11 risks with explicit owners and handling strategies.

The two-outcome success signal (lines 132-135) is particularly strong: it forces the plan to commit to a direction rather than leaving ambiguity.

## Lens 5: Is it code-generation-ready for P15-S1 plan artifact?

**PASS.**

The Handoff For Plan-review section (lines 139-161) provides:

- Exact gate name: `P15-S1 production tracking_error golden evidence plan-review`
- Input artifact reference: `docs/reviews/post-p14-follow-up-planning-20260522.md`
- Output artifact path: `docs/reviews/p15-s1-production-tracking-error-golden-evidence-plan-20260522.md`
- Explicit constraints: do not modify source code, tests, golden files, README, design/control docs, repo-audit, RR-13 data, commit, push, or PR
- Decision logic: if evidence found, specify exact anchors/values/tests/validation/stop conditions; if not, produce blocker record and recommend next gate
- Boundary enforcement: keep annual-report access behind `FundDocumentRepository`; do not introduce excluded capabilities
- Rejection criteria: 6 explicit rejection conditions

An implementation agent receiving this handoff prompt has sufficient context to produce the P15-S1 plan artifact without ambiguity.

## Findings

### F1 [LOW]: Repo-hygiene acknowledgment inconsistency

**Location**: Candidate comparison table, repo-hygiene row (line 50) vs Non-goals section (line 95).

**Evidence**: Line 50 states "Excluded input. This planning task must not read or include `docs/repo-audit-20260521.md`; only public candidate names from control doc may be mentioned." Line 95 states "Do not read, edit, publish, stage, or include `docs/repo-audit-20260521.md`; repo-hygiene candidate names are only acknowledged because they are already public in the control doc."

**Issue**: The candidate table row uses the phrase "only public candidate names from control doc may be mentioned" which could be read as permitting the candidate names to influence the comparison. The Non-goals section is stricter ("only acknowledged because they are already public"). The intent is consistent — exclude the file, only acknowledge names already in control doc — but the phrasing in the candidate table is slightly softer.

**Severity**: LOW. No behavioral impact; both sections agree on the exclusion. The inconsistency is cosmetic.

**Recommendation**: No action required for this planning artifact. If a future planner copies the candidate table row verbatim, the softer phrasing could be tightened to match the Non-goals language.

### No additional findings.

The artifact is well-structured, correctly grounded in design/control truth, has no scope creep, and provides sufficient code-generation guidance for the next gate.

## Validation

- Reviewed artifact: `docs/reviews/post-p14-follow-up-planning-20260522.md` — read in full.
- Design truth: `docs/design.md` — §3.4, §4.4, §7.2 verified as direct evidence for the selection.
- Control truth: `docs/implementation-control.md` — Startup Packet, Active Gate Ledger, P14 archive, Active Residuals verified.
- Excluded input: `docs/repo-audit-20260521.md` — observed as untracked, not read, not referenced.
- No files modified. No commits, pushes, or PR actions performed.
